Skip to main content
Clinical Trials/NCT02345122
NCT02345122
Active, Not Recruiting
N/A

CAMH PARTNERs: Integrated Care for Better Outcomes

Centre for Addiction and Mental Health1 site in 1 country635 target enrollmentNovember 1, 2014

Overview

Phase
N/A
Intervention
Enhanced Usual Care
Conditions
Depression
Sponsor
Centre for Addiction and Mental Health
Enrollment
635
Locations
1
Primary Endpoint
Severity of depressive symptoms, as measured with PHQ-9 during phone interviews at 4, 8, and 12 months
Status
Active, Not Recruiting
Last Updated
19 days ago

Overview

Brief Summary

This research study will evaluate an integrated care model of telephone-based, computer-aided care management using a new role of Mental Health Technician and specialized software to support primary care providers in providing mental health care. The study will compare the effectiveness of this model vs. enhanced usual care in improving initiation of specific treatment by the primary care provider, reduction in severity of symptoms, and improvement in quality of life or functioning.

Detailed Description

This is a randomized clinical trial of an intervention to improve the outcomes of depressive disorders, generalized anxiety, panic disorder, and at-risk drinking or alcohol use disorders in primary care. Two groups will be included: (1) Adult patients who self-refer or are referred to the study by their Primary Care Provider; or (2) patients who are referred by their Primary Care Provider to the tele-mental health consultation service at the Centre for Addiction and Mental Health (Toronto, Ontario). Patients who consent and meet the eligibility criteria will be randomized to either: (1) usual care provided by their Primary Care Provider enhanced by a baseline assessment and follow-up assessments 4, 8, and 12 months later; or (2) an intervention consisting of care provided by their Primary Care Provider enhanced by a baseline assessment, follow-up assessments 4, 8, and 12 months later plus psychoeducation, monitoring, and support offered by telephone by a Mental Health Technician receiving supervision from a project psychiatrist. At baseline and 4, 8, and 12 months later, symptoms, quality of life, and function of all participants will be assessed by telephone by Research Analysts (RAs) blind to the randomization. In addition, at 12 months, patient satisfaction will be assessed. Results of these assessments will be shared with the participant's Primary Care Provider, regardless of randomization. The Primary Care Provider will receive a document summarizing the results of the baseline assessment and the three follow-up assessments for the participants of both the usual care and intervention groups. For participants in the intervention group the Primary Care Provider will also receive treatment recommendations and updates as needed. In the enhanced usual care group, the Primary Care Provider will treat the participant as they deem appropriate. In the intervention group, participants will be assigned to a team constituted by a Mental Health Technician and a psychiatrist. The team will communicate evidence-based treatment recommendations to the Primary Care Provider, for example initiating the use of an antidepressant or referring the participant for therapy or counselling. The Mental Health Technician will offer participants telephone-based psychoeducation about their diagnoses made by their Primary Care Provider or other consulting physicians, their symptoms, and the treatment selected by the Primary Care Provider. The Mental Health Technician will also monitor by phone the progress of treatment and communicate updates to the Primary Care Provider with additional recommendations as required. Thus, the Mental Health Technician will contact the Primary Care Provider on an as needed basis. In addition, for participants who are doing well and for whom no new recommendations are needed, the Mental Health Technician will provide a brief "progress report" to the Primary Care Provider on a monthly basis. In addition, at the completion of the one-year period, the RA will review all the participants' charts to abstract the intervention (e.g., medications, doses, refills) and other health services (e.g., diagnostic tests, referrals, mental health evaluations) they have received during their participation in the study. The chart audit will be conducted using REDCap, a secure application supported by the CAMH Information Management Group (IMG). IMG has all the necessary physical and operational securities in place to meet security and privacy regulations for data transmission and storage using REDCap. Investigators will follow the best practices outlined by IMG to ensure that all data and information is kept private and confidential.

Registry
clinicaltrials.gov
Start Date
November 1, 2014
End Date
December 1, 2026
Last Updated
19 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Benoit Mulsant

Principal Investigator

Centre for Addiction and Mental Health

Eligibility Criteria

Inclusion Criteria

  • Age 18 and older
  • Receiving care from a Primary Care Provider at one of the participating health care organizations
  • Self-referred or referred by a participating primary care provider because of suspected depression, anxiety, alcohol disorder or at risk drinking
  • Having access to a telephone
  • Willingness and ability to converse in English by telephone
  • Corrected auditory acuity that enables to converse in English by telephone
  • Willingness and ability to provide informed consent

Exclusion Criteria

  • Not meeting all inclusion criteria
  • Lifetime primary psychotic illness, bipolar disorder, obsessive-compulsive disorder, or post-traumatic disorder
  • Current substance abuse or dependence (not including alcohol use disorders)
  • Clinically significant cognitive impairment as indicated by a score of 16 or above on the Blessed Orientation Memory Concentration Test
  • High risk for suicide as indicated by the 5-item Paykel Scale
  • Being physically unstable as evidenced by needing to be hospitalized
  • Being expected by one's Primary Care Provider to die during the next 6 months

Arms & Interventions

Enhanced Usual Care

This group will receive Enhanced Usual Care. The subject's Primary Care Provider will receive results of baseline, four, eight, and twelve month assessments examining the subject's symptoms of depression, anxiety, and other mental health problems, use of alcohol and illicit substances, physical pain, and quality of life . If the subjects primary care provider chooses, they can use this information to construct the subject's treatment plan.

Intervention: Enhanced Usual Care

Intervention: Mental Health Technician

The subject's Primary Care Provider will receive results of baseline, four, eight, and twelve month assessments examining the subject's symptoms of depression, anxiety, and other mental health problems, use of alcohol and illicit substances, physical pain, and quality of life and recommendations for treatment. Over a 3-12 months period, the Intervention group will receive a brief, telephone-based intervention by a Mental Health Technician that will focus on monitoring symptoms, treatment adherence, and providing psychoeducation.

Intervention: Intervention: Mental Health Technician

Outcomes

Primary Outcomes

Severity of depressive symptoms, as measured with PHQ-9 during phone interviews at 4, 8, and 12 months

Time Frame: One year

Mixed models will be used to assess changes in depressive symptoms among depressed participants (i.e., those with a PHQ-9 score of 10 or higher at baseline) adjusting for relevant covariates and clustering within subjects over time and within sites. Change in PHQ-9 scores (follow-up minus baseline scores) will be compared between treatment groups with a linear contrast model including the main effects of time, treatment group, and their interaction with the expectation to detect a group effect and a group x time interaction. Time will have 4 levels (Baseline, 4, 8 and 12 months); treatment group will have two levels (EUC and Intervention). We will test the bivariate association between baseline socio-demographics and baseline PHQ-9 scores with treatment group. Variables associated at a significance level of 0.05, will be entered in the model as covariates. Comorbidities will be also entered as control variables.

Secondary Outcomes

  • Severity of anxiety symptoms during the past 2 weeks and number of drinks during the past week(One year)
  • Initiation or change in antidepressant medication documented in the health record at the 4-, 8-, and 12-month follow up(One year)
  • Time to initiation of first specific treatment for depression by the primary care provider(One year)

Study Sites (1)

Loading locations...

Similar Trials